Growth Metrics

Caris Life Sciences (CAI) Short-term Investments (2024 - 2026)

Caris Life Sciences has reported Short-term Investments over the past 2 years, most recently at $1.5 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 30.71% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, down 30.71%, while the annual FY2025 figure was $1.5 million, 30.71% down from the prior year.
  • Short-term Investments for Q4 2025 was $1.5 million at Caris Life Sciences, roughly flat from $1.5 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $2.2 million in Q4 2024 and troughed at $1.5 million in Q2 2025.